177 related articles for article (PubMed ID: 38388419)
1. A case report of abdominal metastatic dermatofibrosarcoma protuberans misdiagnosed as gastrointestinal stromal tumor.
Deng M; Liu Q; Ren L; Yuan W; Xu C; Hou Y
Diagn Pathol; 2024 Feb; 19(1):41. PubMed ID: 38388419
[TBL] [Abstract][Full Text] [Related]
2. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
Kambayashi Y; Kasahara Y; Ohuchi K; Amagai R; Hashimoto A; Asano Y; Fujimura T
Dermatol Ther; 2022 Oct; 35(10):e15736. PubMed ID: 35898161
[TBL] [Abstract][Full Text] [Related]
5. An unusual clinical presentation of myxoid dermatofibrosarcoma protuberans with a prominent vasculature: A potential pitfall in the diagnosis of myxoid soft tissue tumors.
Tran P; Henderson GP; McLemore M
J Cutan Pathol; 2018 Jun; 45(6):419-422. PubMed ID: 29468850
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Imatinib Mesylate Treatment in a Patient with Dermatofibrosarcoma Protuberans with Pulmonary and Pancreatic Metastases.
Tatai T; Gomi D; Fukushima T; Kobayashi T; Sekiguchi N; Sakamoto A; Sasaki S; Koizumi T; Sano K
Intern Med; 2016; 55(17):2507-11. PubMed ID: 27580559
[TBL] [Abstract][Full Text] [Related]
7. Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.
Navarrete-Dechent C; Mori S; Barker CA; Dickson MA; Nehal KS
JAMA Dermatol; 2019 Mar; 155(3):361-369. PubMed ID: 30601909
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
[TBL] [Abstract][Full Text] [Related]
9. Autoamputation of Dermatofibrosarcoma Protuberans: A Novel and Rare Presentation of a Familiar Entity.
Jebastin Thangaiah J; Williamson SR; Pimentel J; Perry K
Int J Surg Pathol; 2019 Aug; 27(5):531-534. PubMed ID: 30813811
[TBL] [Abstract][Full Text] [Related]
10. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans: a tumor in the wide spectrum of the bland-looking spindle cell lesions of the breast.
Vecchio GM; Broggi G; Mulè A; Piombino E; Magro G
Pathologica; 2019 Sep; 111(3):87-91. PubMed ID: 31748754
[TBL] [Abstract][Full Text] [Related]
12. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review.
Banach BS; Antic T; Bridge JA; Cipriani NA; Frye L; Krausz TN; Biernacka A
Diagn Cytopathol; 2019 Aug; 47(8):797-802. PubMed ID: 30919592
[TBL] [Abstract][Full Text] [Related]
15. Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report.
Lemm D; Muegge LO; Hoeffken K; Aklan T; Mentzel T; Thorwarth M; Schultze-Mosgau S
Oral Maxillofac Surg; 2008 Dec; 12(4):209-13. PubMed ID: 18751744
[TBL] [Abstract][Full Text] [Related]
16. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report.
El Hachem M; Diociaiuti A; Latella E; Zama M; Lambiase C; Giraldi L; Surrenti T; Callea F
Pediatr Dermatol; 2013; 30(5):e74-7. PubMed ID: 23534369
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans - a rare, slow growing benign, locally agressive dermal sarcoma: A case report.
Gurz AA; Gumus M
J Pak Med Assoc; 2019 Oct; 69(10):1550-1552. PubMed ID: 31622315
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a case report.
Hrudka J; Charvát M; Grossmann P; Kinkor Z
Cesk Patol; 2020; 56(2):89-93. PubMed ID: 32493025
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans: a rare entity and review of the literature.
Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K
J BUON; 2014; 19(1):34-41. PubMed ID: 24659640
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
